Lv51
1380 积分 2021-09-15 加入
American Society for Clinical Pharmacology and Therapeutics
3个月前
已完结
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations
4个月前
已完结
Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes
4个月前
已完结
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
6个月前
已完结
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
7个月前
已完结
AB1034 CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
7个月前
已完结
Trends in the drug target landscape for autoimmune diseases
7个月前
已完结
Selection of positive controls and their impact on anti-drug antibody assay performance
8个月前
已完结
Selection of positive controls and their impact on anti-drug antibody assay performance
11个月前
已关闭
Development And Validation of Cell-Based Assays For The Detection of Neutralizing Antibodies to Drug Products: A Practical Approach
11个月前
已完结
皖公网安备34019202002308
